![Ken Warrington](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Ken Warrington
Director/Board Member at BIOSTEM TECHNOLOGIES INC
Net worth: - $ as of 2024-05-30
Ken Warrington active positions
Companies | Position | Start | End |
---|---|---|---|
BIOSTEM TECHNOLOGIES INC | Director/Board Member | 2022-02-28 | - |
Corporate Officer/Principal | 2019-10-28 | 2022-02-28 |
Career history of Ken Warrington
Former positions of Ken Warrington
Companies | Position | Start | End |
---|---|---|---|
GENSCRIPT PROBIO USA INC. | Corporate Officer/Principal | 2019-12-31 | 2021-11-30 |
Biostem Life Sciences, Inc. | Chief Operating Officer | 2019-05-31 | 2020-04-30 |
Lacerta Therapeutics, Inc.
![]() Lacerta Therapeutics, Inc. BiotechnologyHealth Technology Lacerta Therapeutics, Inc. operates as a a clinical stage gene therapy company. The firm engages in development, production, and application of AAV vectors. The company was founded by Nicholas Muzyczka, Barry Byrne, Arun Srivastava, Coy Heldermon, Sergei Zolothukin, Kenneth Warrington, Ronald Mandel, Toadd E. Golde and Edgardo Rodriguez in 2017 and is headquartered in Alachua, FL. | Chief Tech/Sci/R&D Officer | 2017-10-31 | 2019-04-30 |
Training of Ken Warrington
The St. Lawrence College | Undergraduate Degree |
University of Florida | Doctorate Degree |
Statistics
International
United States | 6 |
United Kingdom | 2 |
Operational
Corporate Officer/Principal | 2 |
Director/Board Member | 1 |
Chief Operating Officer | 1 |
Sectoral
Health Technology | 3 |
Consumer Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 1 |
---|---|
BIOSTEM TECHNOLOGIES INC | Health Technology |
Private companies | 3 |
---|---|
Biostem Life Sciences, Inc. | |
GENSCRIPT PROBIO USA INC. | |
Lacerta Therapeutics, Inc.
![]() Lacerta Therapeutics, Inc. BiotechnologyHealth Technology Lacerta Therapeutics, Inc. operates as a a clinical stage gene therapy company. The firm engages in development, production, and application of AAV vectors. The company was founded by Nicholas Muzyczka, Barry Byrne, Arun Srivastava, Coy Heldermon, Sergei Zolothukin, Kenneth Warrington, Ronald Mandel, Toadd E. Golde and Edgardo Rodriguez in 2017 and is headquartered in Alachua, FL. | Health Technology |
- Stock Market
- Insiders
- Ken Warrington
- Experience